Health Professional Radio - Podcast

Dr. Maxime Descoteaux, Co-founder and CSO of Imeka, "the only company to combine diffusion and AI to map white matter integrity" discusses the use of white matter free water biomarker in Alzheimer's disease and why scientists should change their focus from grey matter to white matter when it comes to evaluating Alzheimer’s disease. He also comments on MRI's analyzed from INmune Bio's XPro1595Phase 1b Clinical Trial.